Open Access Mini Review

Toxicity of maintenance drugs in Inflammatory Bowel Disease

Abdo Saad MD1*

1Department of Internal Medicine, Section of Gastroenterology, Lebanese American University, Lebanon

Corresponding Author

Received Date: August 04, 2021;  Published Date: September 07, 2021


Inflammatory bowel disease is a chronic condition requiring long-term treatment with immunosuppressive medications. There is concern regarding the risks of drug-related toxicity particularly the risk of infections and the risk of malignancy. Pregnancy requires a particular consideration due to the implications from the exposure to the fetus and elderly patients may be at a higher risk of toxicity that merits special precautions.

Keywords: 5-Aminosalicylates; Immunomodulators; Biologics; Toxicity; Inflammatory Bowel Disease; Crohn’s Disease; Ulcerative Colitis

Signup for Newsletter
Scroll to Top